"ALOFT - Aliskiren Observation of Heart Failure Treatment": Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure
Clinical trial NCT00219011 · COMPLETED
Trial details
- NCT number
- NCT00219011
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2007-02-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.